News

RSS feed

Genethon Lecture Series:2013, July 15th

Monday July 15th, 2013: “Design and delivery of micro-dystrophins for DMD therapy” Pr Jeffrey S. Chamberlain, University of Washington School of Medicine, Depts. of Neurology, Medicine and Biochemistry, Seattle, USA

Genethon Lecture Series:2013, July 12th

Friday July 12th, 2013: “HIV integration and regulation” Dr Frederic D. Bushman, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA.

Genethon Lecture Series:2013, May 29th

Wednesday May 29th, 2013: “Gene therapy for beta-thalassemia: The challenge of a new cure” Dr Giuliana Ferrari, HSR-TIGET, Universita Vita-Salute San Raffaele, Milan, Italy

Genethon Lecture Series:2013, February 19th

Tuesday February 19th,2013 : “Identification of tumorigenic pathways from large-scale genomic data” Dr Silvio Bicciato, Center for Genome Research, Department of Life Sciences, University of Modena and Reggio Emilia, Italy

Genethon Lecture Series:2013, February 13th

Wednesday February 13th,2013 : « Production of AAV vectors in Baculoviruses » Dr Robert M. Kotin, National Institutes of Health (NIH), Laboratory of Molecular Virology and Gene Therapy, Bethesda, US.

La Gazette du Laboratoire

Genethon BioProd : A manufacturing capacity for gene therapy products which is unique in the world

Read the article [PDF in FRENCH – 360 Ko]

Author : S. Denis

For more information

La Gazette du Laboratoire

New challenges for AFM-Telethon with the launch of the Biotherapies Institute for Rare Diseases which includes Genethon.

Read the article [PDF in FRENCH – 400 Ko]

For more information

Telethon 2012: 81,065,239€. Thank you for having met the challenge

This year’s Telethon will remain the challenge of all challenges: the challenge of donors and volunteers in the face of crisis, the challenge of researchers and families in the face of disease … Together, we have tackled them, with determination and courage, all united by the same desire: win! The counter of Telethon 2012 stopped … [Read more]

Nature Medicine

Gene therapies advance, but some see manufacturing challenges

“Gene therapy has traveled a long and winding road to the clinic. The field famously hit a major roadblock 13 years ago when the teenager Jesse Gelsinger suffered a fatal immune reaction in response to a gene therapy product designed to correct his rare liver disease, leading to a perception…”

Author : Elie Dolgin

 Read on website

Industrie Pharma

Genethon takes on more projects

Read the article [PDF IN FRENCH – 561 ko]